raloxifene hydrochloride has been researched along with Necrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greish, K; Nehoff, H; Rosengren, RJ; Taurin, S; van Aswegen, T | 1 |
| Bofilis, E; Iliodromitis, EK; Kremastinos, DT; Kyriakides, ZS; Sbarouni, E | 1 |
| Nakamura, T | 1 |
1 review(s) available for raloxifene hydrochloride and Necrosis
| Article | Year |
|---|---|
[Adverse events of drugs for the treatment of osteoporosis].
Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Cholecalciferol; Diphosphonates; Gastrointestinal Diseases; Hot Flashes; Humans; Hypercalcemia; Jaw Diseases; Macular Edema; Necrosis; Osteoporosis; Raloxifene Hydrochloride; Venous Thrombosis | 2007 |
2 other study(ies) available for raloxifene hydrochloride and Necrosis
| Article | Year |
|---|---|
A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA, Neoplasm; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Male; Maleates; Matrix Metalloproteinase 9; Micelles; Nanoparticles; Necrosis; Neoplasm Invasiveness; Polystyrenes; Prostatic Neoplasms, Castration-Resistant; Protein Biosynthesis; Raloxifene Hydrochloride; Receptors, Estrogen; Spheroids, Cellular | 2014 |
Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size.
Topics: Animals; Drug Therapy, Combination; Estrogen Antagonists; Estrogens; Female; Hypercholesterolemia; Medroxyprogesterone; Myocardial Infarction; Necrosis; Ovariectomy; Progesterone Congeners; Rabbits; Raloxifene Hydrochloride | 2003 |